Anti-dsDNA
Anti-dsDNA measures antibodies that target double-stranded DNA, which are often elevated in autoimmune conditions like systemic lupus erythematosus (SLE).
Anti-dsDNA antibodies are key indicators of autoimmune diseases, particularly SLE.
Key facts at a glance
- Units
- IU/mL
- Clinical utility
- monitoring
- Result kind
- quantitative
- FDA-cleared
- Roche Anti-dsDNA, Abbott Anti-dsDNA, Siemens Anti-dsDNA, Inova Anti-dsDNA
Anti-double-stranded DNA (anti-dsDNA) antibodies are a type of autoantibody that target the DNA within cells. These antibodies are highly specific for systemic lupus erythematosus (SLE), making them a critical biomarker for diagnosing and monitoring this condition.
Elevated levels of anti-dsDNA antibodies are typically associated with increased disease activity in SLE patients. Regular monitoring of these levels helps in assessing the effectiveness of treatment and predicting potential flares.
The presence of anti-dsDNA antibodies is not exclusive to SLE; they can also be found in other autoimmune disorders, albeit at lower levels. Therefore, interpreting anti-dsDNA results requires careful clinical correlation.
Frequently asked questions
What does a positive anti-dsDNA test mean?
Can anti-dsDNA levels change over time?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy